EUGLYCEMIC DKA WITH SGLT-2 INHIBITORS

被引:0
|
作者
Zuniga, Eric [1 ]
Lee, Emily [1 ]
Daniel, Raeye [1 ]
Zhou, Leon [1 ]
Vaidya, Ajay [1 ]
Alderwish, Edris [1 ]
机构
[1] LAC USC Med Ctr, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1346-120
引用
收藏
页码:2981 / 2981
页数:1
相关论文
共 50 条
  • [21] EUGLYCEMIC DKA FROM AN SGLT2 INHIBITOR IN A HEART TRANSPLANT PATIENT
    McGuiness, Mariel
    Paschke, Kelly
    Foreman, Beth
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 2268 - 2268
  • [22] Outcome studies on SGLT-2 inhibitors
    Seufert, J.
    Laubner, K.
    INTERNIST, 2019, 60 (09): : 903 - 911
  • [23] SGLT2 Inhibitors and Euglycemic Ketoacidosis
    Masuta, Pardeep
    Johri, Geetanjali
    Paul, Manju
    AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (04) : E498 - E500
  • [24] Euglycemic Diabetic Ketoacidosis, SGLT-2 Inhibitors and COVID-19; The Murphy Law of COVID-19
    Hassan, A.
    Salat, H.
    Ahmed, A.
    Khan, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [25] Adverse effects and safety of SGLT-2 inhibitors
    Halimi, S.
    Verges, B.
    DIABETES & METABOLISM, 2014, 40 : S28 - S34
  • [26] SGLT-2 Inhibitors and Regenerative Cell Exhaustion
    Hess, David A.
    Terenzi, Daniella C.
    Verma, Subodh
    CELL METABOLISM, 2020, 31 (05) : 884 - 885
  • [29] SGLT-2 inhibitors for the prevention of recurrent nephrolithiasis
    Sakhaee, Khashayar
    BMJ-BRITISH MEDICAL JOURNAL, 2024, 387
  • [30] SGLT-2 inhibitors and their potential in the treatment of diabetes
    Rosenwasser, Rebecca F.
    Sultan, Senan
    Sutton, David
    Choksi, Rushab
    Epstein, Benjamin J.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2013, 6 : 453 - 467